Biotech Companies Are Increasingly Worried About Trump's Visa Crackdown: Bloomberg

Bloomberg

Published on 24 Feb 2017

Feb.24 -- From tiny startups to global giants, the companies that sustain the $324 billion U.S. biotech industry are increasingly alarmed as President Donald Trump considers following his controversial travel ban with restrictions on skilled foreign immigrants. Bloomberg's Doni Bloomfield reports from the nation's biotech hub in Cambridge, Massachusetts.